Australia markets closed

Eupraxia Pharmaceuticals Inc. (EPRX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.9500+0.0600 (+2.08%)
At close: 04:00PM EDT
2.9300 -0.02 (-0.68%)
After hours: 07:28PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
22,464
20,563
13,630
9,679
859.781
Selling general and administrative
8,540
7,284
3,988
8,887
1,270
Total operating expenses
31,004
27,847
17,617
18,678
2,246
Operating income or loss
-31,004
-27,847
-17,617
-18,678
-2,246
Interest expense
1,200
1,170
982.856
1,297
1,882
Total other income/expenses net
142.349
-775.15
-822.255
-3,461
116.761
Income before tax
-31,125
-28,930
-18,991
-23,370
-4,011
Income tax expense
41.423
36.423
0
-
-
Income from continuing operations
-31,167
-28,966
-18,991
-23,370
-4,011
Net income
-30,368
-28,221
-18,490
-22,990
-3,997
Net income available to common shareholders
-30,368
-28,221
-18,490
-22,990
-3,997
Basic EPS
-1.53
-1.17
-0.96
-1.88
-0.31
Diluted EPS
-1.53
-1.17
-0.96
-1.88
-0.31
Basic average shares
22,702
24,147
19,285
12,406
12,865
Diluted average shares
22,702
24,147
19,285
12,406
12,865